Cover Image

Improving Culture yield rates for clostridioides difficile by using CHROMagarTM

Saved in:

Bibliographic Details
Main Authors:	T. Yi-Chun (Author), C. Yi-Shun (Author), H. Ya-I (Author), J. Yue-Jiau (Author), Y. Hsiu-Chou (Author), Y. Pey-Luen (Author), S. Pei-Lan (Author), F. Hui-Min (Author), C. Shin-Ying (Author), Po-Ren H (Author)
Format:	Book
Published:	Elsevier, 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a real-time PCR assay and comparison to CHROMagarTM STEC to screen for Shiga toxin-producing Escherichia coli in stool, Cape Town, South Africa
by: John B. Kalule, et al.
Published: (2017)

Clostridioides difficile Infection
Published: (2022)

Opportunities for Nanomedicine in <i>Clostridioides difficile</i> Infection
by: Pei-Wen Wang, et al.
Published: (2021)

Diagnostic Methods of <i>Clostridioides difficile</i> Infection and <i>Clostridioides difficile</i> Ribotypes in Studied Sample
by: Elena Novakova, et al.
Published: (2021)

Clostridioides difficile: A diagnostic intervention
by: Majd Alsoubani, et al.
Published: (2022)

Effect of Doxycycline in Decreasing the Severity of <i>Clostridioides difficile</i> Infection in Mice
by: Bo-Yang Tsai, et al.
Published: (2022)

Expansion of a versatile pathogen: Clostridioides difficile
by: Tereena Lucas, et al.
Published: (2024)

Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
by: Oliver MB, et al.
Published: (2022)

Clostridioides difficile infection: a comprehensive review for primary providers
by: Cortés Pedro, et al.
Published: (2021)

Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity
by: Li‐Xing Yang, et al.
Published: (2023)

Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients
by: Diaa Alrahmany, et al.
Published: (2021)

Outbreak of Clostridioides difficile infection in Silesian district hospital
by: Klaudia T. Szarek, et al.
Published: (2023)

Introduction to the Special Issue on <i>Clostridioides difficile</i>
by: Guido Granata, et al.
Published: (2021)

Clostridioides Difficile Enteritis: Case Report and Literature Review
by: Artsiom Klimko, et al.
Published: (2022)

Current Diagnostic and Treatment Approach of Clostridioides difficile Infection
by: Bella Yunita, et al.
Published: (2023)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021)

Real-world effectiveness of fidaxomicin in patients at high risk of Clostridioides difficile recurrence
by: Benjamin Colwell, et al.
Published: (2024)

Impact of Clostridioides difficile Reporting on Antimicrobial Therapy Days Directed at Treatment of C. difficile Infections
by: Ardath Plauche, et al.
Published: (2024)

Detecting Clostridioides (Clostridium) difficile using canine teams: What does the nose know?
by: M.K. Charles, et al.
Published: (2019)

Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection
by: Jesse Fajnzylber, et al.
Published: (2024)

Clostridioides Difficile: A Concise Review of Best Practices and Updates
by: Abdelrahman Yakout, et al.
Published: (2024)

Clostridioides difficile infections in Saudi Arabia: Where are we standing?
by: Najla A. Obaid, et al.
Published: (2020)

Clostridioides difficile infection in intensive care units in nursing practice
by: Izabela Fajfer-Gryz, et al.
Published: (2020)

Clostridioides difficile infection leading to fulminant colitis with toxic megacolon
by: Fareed Rajack, et al.
Published: (2023)

Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
by: Katelyn A. Bustin, et al.
Published: (2023)

Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species
by: Marol Serhat, et al.
Published: (2003)

Hospital-Onset Clostridioides difficile infection in chronic kidney disease patients
by: Anita Shallal, et al.
Published: (2024)

Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
by: Andrew T. Dysangco, et al.
Published: (2022)

Clostridioides difficile infection in trials of short versus long duration of antimicrobials
by: Dimitri M. Drekonja, et al.
Published: (2024)

Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
by: Zeitler Kristen, et al.
Published: (2023)

The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study
by: Uffe Christian Braae, et al.
Published: (2020)

Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore Outgrowth
by: Suvash Chandra Ojha, et al.
Published: (2021)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
by: Sebastian Heber, et al.
Published: (2022)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
by: Kullar R, et al.
Published: (2020)

Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019
by: Ahmed Mohamed Mostafa Abdrabou, et al.
Published: (2021)

Impact of <i>Clostridioides difficile</i> Therapy on Nosocomial Acquisition of Vancomycin-Resistant Enterococci
by: Carlos L. Correa-Martínez, et al.
Published: (2021)

Melatonin as an Antimicrobial Adjuvant and Anti-Inflammatory for the Management of Recurrent <i>Clostridioides difficile</i> Infection
by: S. Scott Sutton, et al.
Published: (2022)

The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against <i>Clostridioides Difficile</i>
by: Lillian Yu, et al.
Published: (2020)

A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections
by: Daniel C. Malone, et al.
Published: (2023)

Breaking the Reflex: Impact in Hospital-Acquired Infection Incidence for Clostridioides difficile Infection
by: Mamta Sharma, et al.
Published: (2024)